Posted on

Inbiodrain: a new lyophilised product to treat cellulite with hyaluronidase.

Inbiodrain: a new lyophilised product to treat cellulite with hyaluronidase.

Inbiodrain is the new enzyme treatment with hyaluronidase from the Inbiotec range, for anti-cellulite treatment.

IT Pharma presents a new lyophilised product to treat cellulite with hyaluronidase.

Inbiodrain is the new enzyme treatment with hyaluronidase from the Inbiotec range, for anti-cellulite treatment.

Inbiodrain is the new enzyme treatment with hyaluronidase from the Inbiotec range, for anti-cellulite treatment. This fourth new lyophilised product by IT Pharma, makes the most of the characteristics of this format to strengthen the activity of the ingredients to increase dermal permeability. Inbiodrain helps to increase lymphatic drainage and to promote blood flow. It facilitates the degradation of the polysaccharide molecules responsible for the excessive accumulation of water in a tissue and improves fluid retention in tissue.

Hyaluronidase is an enzyme that catalyses the hydrolysis of certain complex carbohydrates and depolymerizes hyaluronic acid, leading to its natural breakdown. Likewise, hyaluronidase, applied for cosmetic purposes, helps to drain drain areas with retained fluids. It increases dermal permeability, lymphatic drainage, blood flow and also improves the penetration of active-ingredients.

For more information on the Inbiotec range, contact your local IT Pharma distributor or send an email to : info@itpharmalab.com

Share on facebook
Facebook
Share on twitter
Twitter
Share on linkedin
LinkedIn

Make a comment

Posted on

Inbioshine: new lyophilized brightening treatment of Inbiotec

Inbioshine: new lyophilized brightening treatment of Inbiotec

In Ibioshine, L-Glutathione with Vitamin C (Ascorbic acid) forms a natural complex and in combination they promote the whitening and anti-aging of the skin, to the maximum level.

IT Pharma intrduces a new lyophilized for anti-aging and skin luminosity

Inbioshine , L-Glutathione with Vitamin C (Ascorbic acid) forms a natural complex and in combination they promote the whitening and anti-aging of the skin, to the maximum level.

Glutathione is a powerful anti-oxidant containing abundant aminoacids. The best part of this anti-oxidant is that it is extremely safe and contains no free radicals or toxins that could damage the skin. In fact, it helps to cleanse the skin and remove all impurities, making it possible to achieve a much brighter complexion. With this product, you can expect your hyper-pigmentation marks to visibly diminish. It also helps to activate enzymes that play an important role in the elimination of toxins.

Vitamin C provides sun protection: over-exposure to the sun may cause hyper-pigmentation and sun spots.

Inbioshine presents itself as a new solution for antioxidant action to protect against the damage of free radicals that could accelerate the aging of the skin, capacity to even the tone and lighten the skin, and lessens dark spots caused by acne and prevents blackheads.
For further information about Inbiotec, please contact with your local distributor or send an email to: info@itpharmalab.com

Share on facebook
Facebook
Share on twitter
Twitter
Share on linkedin
LinkedIn

Make a comment

Posted on

IT Pharma is starting out in China

IT Pharma is starting out in China

IT Pharma has reached an agreement for the distribution of its core professional cosmetic lines in China with the company WheatWave (HK) Limited, based in Hong Kong. This agreement is directed at introducing the core products of the IT Pharma, Inbiotec and Ethernium lines, all made and developed in Spain.

This Spanish professional cosmetics company has signed an agreement with the Chinese company Wheat Wave for the marketing of its lines throughout the People’s Republic of China.

This is an exciting business opportunity for this Spanish group as part of its international business growth plan, which was set in motion two years ago. In this way IT Pharma will access the market in the world’s most populous country, with 1,395 million inhabitants and which is the world’s leading economic power in terms of GDP. The professional cosmetics sector in China has been strengthened by the growth of the urban middle class with purchasing power levels that are comparable to the European ones, with the growing urbanisation of the population (ICEX 2018) and the new economic model for domestic consumption. Over the last few years, this has led to the presence of non-local brands in the country, as is the case of the cosmetics sector. IT Pharma aims to strongly focus on this constantly growing market, through its relations with this Chinese company.

Furthermore, Wheat Wave (HK) Limited has a network of collaborators and influencers that are dedicated to using modern and direct ways of reaching end consumers. In the words of Xu Wei, the company’s legal representative, “we decided on IT Pharma after trying different European lines, and it was basically the quality of the product that tipped the scales in its favour. These are lines of the highest quality and considerable safety, a key factor for us”. Wei added that “it was very important to have a partner in whom we could place our full trust and confidence, and IT Pharma has always made us feel like we are being heard.


We’re currently working with more than 50 influencers and celebrities throughout the country, targeting a young, modern and independent audience, which is increasingly more numerous in our country”.

Alvaro López, Sales Executive of this Spanish group highlighted the fact that “for us, the introduction of our lines in China means that the presence of our brand in Asia is growing exponentially, strengthening our global image. Our relationship with WheatWave has been very simple and satisfactory right from the start, thanks to its experience in the BTB and BTC markets and also to its networking capacity in its market. We are aiming to make China one of our key markets in the international sector and we hope to maintain a business relationship that is long-lasting and prosperous for both parties. We’re really happy”.

IT Pharma will be present at the Cosmoprof ASIA international cosmetics fair, set to take place in Hong Kong from the 13th to 15th November, where the company will be showcasing its key innovations in the IT Pharma and Inbiotec Smart Cosmetics lines.

Share on facebook
Facebook
Share on twitter
Twitter
Share on linkedin
LinkedIn

Make a comment

Posted on

IT PHARMA ARRIVES IN BRAZIL

IT PHARMA ARRIVES IN BRAZIL

IT Pharma, the Pamplona-based Spanish professional cosmetics brand, continues its internationalisation project with the launch of IT Pharma Brasil, opening the door to one of the most important cosmetics markets in Latin America. Grupo Perlatenda, a Brazilian holding company with great experience in the sector, will handle the distribution and marketing of the company’s main product lines.

Grupo Perlatenda, a Brazilian holding company, will handle the distribution of the firm’s cosmetic products in the country.

Grupo Perlatenda, a Brazilian holding company, will handle the distribution of the firm’s cosmetic products in the country.

IT Pharma, the Pamplona-based Spanish professional cosmetics brand, continues its internationalisation project with the launch of IT Pharma Brasil, opening the door to one of the most important cosmetics markets in Latin America. Grupo Perlatenda, a Brazilian holding company with great experience in the sector, will handle the distribution and marketing of the company’s main product lines.


For Grupo Perlatenda this means that ‘the group, which is internationally known as a market leader in Latin America thanks to its sales network with more than twenty-seven thousand authorised representatives, will finally be able to offer Brazil’s finest professionals the best professional dermatological cosmetics product line around. IT Pharma is coming to Brazil as a European market leader and will consolidate its leading position this year in Latin America without a shadow of a doubt,’ states Nazir Angelo Disanto, the CEO of the Brazilian holding company.

Sergio García, Export Manager at IT Pharma, points out that ‘entering the Brazilian market is a major step for us because the opportunity for the growth and development of our brand in this cosmetics sector is huge. We are very pleased that IT Pharma Brasil is finally a reality.’

Alvaro López, Business Development Manager at IT Pharma, highlights ‘the importance of guaranteeing and certifying the absolute safety of our vials and ampoules. This is a non-negotiable feature of our company and something which Perlatenda shared from the outset, making for a highly satisfactory professional relationship between us.’ López adds that this first step is the ‘first stone laid in what will be a lasting and fruitful relationship, our chief objective being to offer the Brazilian public a safe product of the highest quality.’

IT Pharma Brasil is set to officially present itself tomorrow at Estetika, the biggest professional cosmetics congress in the country, held from the 29th of August to the 1st of September in Sao Paulo.

Share on facebook
Facebook
Share on twitter
Twitter
Share on linkedin
LinkedIn

Make a comment

Posted on

IT Pharma opens its first beauty centre in Portugal

IT Pharma opens its first beauty centre in Portugal

Daniela Stoica, the distributor for IT Pharma Portugal, is to manage the first centre in Lisbon for treatments and training services

The range of services offered by the centre will include treatments directed at the end customer, as well as training workshops and courses for professionals in the sector, conferences with experts in different fields and demonstrations and the sale of products from the company’s different lines.

According to its manager, the goal is to “offer a range of treatments that are particularly focussed on advanced aesthetics, with top quality products and proven safety.” The treatment range available at the beauty centre will include facials and body care, all using product lines, services and technology that are exclusive to IT Pharma.

In the words of Daniela, “the goal of this first beauty centre is to offer customers excellent service, ongoing training for professionals in the sector and to make it possible to expand the company’s product lines throughout the country. We’re really excited about this new step forward”.

Share on facebook
Facebook
Share on twitter
Twitter
Share on linkedin
LinkedIn

Make a comment

Posted on

Arctic Noir: The new soothing, hydrating face mask by IT Pharma

Arctic Noir: The new soothing, hydrating face mask by IT Pharma

This new item from the IT Pharma professional cosmetic product range is intended to offer aestheticians a tool for performing deep skin hydration or for completing any other type of slightly aggressive treatment such as micro-needling.

IT Pharma is launching Arctic Noir, a soothing, hydrating face mask that is perfect for applying after aesthetic or medical treatment, as it helps to reduce inflammation and has a calming effect on the skin.

This new mask is rich in Aloe Vera and Witch-hazel extract, boosting skin hydration by creating a moisture barrier against dryness. Centella asiatica and green tree extract help to relieve rough skin, for a healthy, glowing look. This mask also has an anti-wrinkle effect.

This new item from the IT Pharma professional cosmetic product range is intended to offer aestheticians a tool for performing deep skin hydration or for completing any other type of slightly aggressive treatment such as micro-needling.

Share on facebook
Facebook
Share on twitter
Twitter
Share on linkedin
LinkedIn

Make a comment

Posted on

Inbiotec Amber: hyaluronic with succinic acid, the new injectable by IT Pharma

Inbiotec Amber: hyaluronic with succinic acid, the new injectable by IT Pharma

Next Friday, at the 34th National Congress of SEME, IT Pharma is to present Inbiotec Amber, with a paper by Dr. José Luis Latorre

Next Friday, at the 34th National Congress of SEME, IT Pharma is to present Inbiotec Amber, with a paper by Dr. José Luis Latorre

Inbiotec Medical Devices, the new line of healthcare products developed by the IT Pharma group, is bringing its first product to market: Inbiotec Amber, a new injectable comprising 1.1% hyaluronic acid and 1.6% succinic acid. In a paper entitled: A new concept in mesotherapy: Discover the benefits of succinic acid, Doctor Latorre will explain the benefits of this active ingredient sourced from amber.

With this new line of healthcare products for aestheticians and dermatologists, IT Pharma aims to provide professionals with a safe, innovative product that stands out due to its combination of top quality ingredients.

The presentation is set to take place on Friday 22nd in Malaga, Conference Room 1 and will count on the presence of Dr. Pilar Garcia-Las Heras as moderator.

Share on facebook
Facebook
Share on twitter
Twitter
Share on linkedin
LinkedIn

Make a comment

Posted on

“Biopeptides are going to be the key ingredients in the cosmetic medicine treatments of the future”

“Biopeptides are going to be the key ingredients in the cosmetic medicine treatments of the future”

Dr Yong Ji Chung, president of the biotechnology multinational Caregen, gave a paper on ‘Biopeptides in cosmetic medicine and their future in the sector’ at a conference organised by IT Pharma.

The conference on cosmetic medicine, organised by IT Pharma, was held on Saturday 1 September in Hotel Hiberus in Zaragoza.

Last weekend, Dr Chung, president and founder of the Korean multinational Caregen Co., which produces and distributes cosmetic medical products, gave a paper on ‘Biopeptides in cosmetic medicine and their future in the sector’ at Hotel Hiberus in Zaragoza.

In it he pointed out that ‘a great many ingredients have been used for cosmetic medicine in the past, but modern-day biopeptides are much more powerful and effective for a multitude of cases and patients.’ While the Korean company is involved in ongoing research into these amino acid chains, its president stressed that ‘Caregen has managed to develop more than 450 biopeptides, which will generate numerous applications in the future. Many active ingredients have been used in the aesthetic market over time, but peptides are much more powerful in comparison. That is because they act just like our own growth factors and cytokines, and this makes them much more effective. So, in view of the current conditions of the aesthetic market, peptides are going to be the key ingredients in treatments in the future“.

The event organised by IT Pharma in collaboration with TOV Medical also included a round table afterwards with the participation of Dr Chung, Dr Juan Miguel Pérez Díaz from Madrid’s Clínica Pérez Díaz, Dr Rafael Spagnuolo from Clínica Spagnuolo in Marbella and Dr Inma González, the founder of CISIG. The participants shared their experiences with current cosmetic medical cases, the types of treatment most demanded by patients nowadays, the challenges facing the sector and new trends on their way in.

PICTURES ON FACEBOOK

Share on facebook
Facebook
Share on twitter
Twitter
Share on linkedin
LinkedIn

Make a comment

Posted on

IT Pharma attends the IMCAS World Congress in Paris

IT Pharma attends the IMCAS World Congress in Paris

IT Pharma attended the IMCAS World Congress in Paris to introduce Prostrolane Inner B of Caregen

The Navarran group made the most of the congress to sign the exclusive distribution agreement in Spain and Mexico for the Prostrolane line by Caregen.

On 1st February, IT Pharma attended the IMCAS WORLD CONGRESS on aesthetic medicine, which took place in Paris, where it collaborated by exhibiting and introducing Prostrolane Inner B., by Caregen Co., assisted by Dr Chung, CEO of the Korean firm.

Doctor Juan Miguel Pérez from the Pérez Díaz Clinic – a regular collaborator of the group – gave a speech about the product and revealed ten clinical cases in which the effectiveness and quality of Inner B. was left undisputable, accompanying other collaborating medical professionals from the Korean group.

Taking full advantage of the visit to the French capital, an importation and exclusive distribution agreement was signed with Caregen for the Prostrolane line. The agreement was signed by Dr Chung and the IT Pharma management, which has reached an agreement with TOV Medical, collaborators in distribution in Spain, who have been given the responsibility for marketing Inner B. within Spain.

The congress concluded with a gala dinner, attended by all the trusted distributers and doctors from the Korean firm.

Share on facebook
Facebook
Share on twitter
Twitter
Share on linkedin
LinkedIn

Make a comment